(Q47221312)

12 January 2018

title

The use of low molecular weight heparin in pediatric patients: a prospective cohort study (English)

1 reference

12 January 2018

0 references

1 reference

Dix D

1

1 reference

12 January 2018

Andrew M

2

1 reference

12 January 2018

Marzinotto V

3

1 reference

12 January 2018

Charpentier K

4

1 reference

12 January 2018

Bridge S

5

1 reference

12 January 2018

Monagle P

6

1 reference

12 January 2018

deVeber G

7

1 reference

12 January 2018

Leaker M

8

1 reference

12 January 2018

Chan AK

9

1 reference

12 January 2018

Massicotte MP

10

1 reference

12 January 2018

language of work or name

English

0 references

publication date

1 April 2000

1 reference

12 January 2018

The Journal of Pediatrics

published in

1 reference

12 January 2018

volume

136

1 reference

12 January 2018

issue

4

1 reference

12 January 2018

page(s)

439-445

1 reference

12 January 2018

Coagulation Studies in Extremely Premature Infants

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

Management of major thromboembolic complications of umbilical artery catheters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

Thrombotic disease in newborn infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

Neonatal thrombotic disease: prevention, diagnosis, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

Antithrombotic therapy in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

Guidelines for antithrombotic therapy in pediatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

Antithrombotic therapy for venous thromboembolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

Heparin therapy in pediatric patients: a prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

Neonatal symptomatic thromboembolism in Germany: two year survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

Low-molecular-weight heparins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990005-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(00)90005-2

1 reference

12 January 2018

1 reference

12 January 2018